
Trending Now
1
FDA Grants Priority Review to Gepotidacin for Gonorrhea
2
Dalbavancin Holds Its Own Against S. aureus Bacteremia, Study
3
Approved: HPV-Targeted Immunotherapy for Recurrent Respiratory Papillomatosis
4
UV Light Linked With Lower Respiratory Infection Rates
5
IDSA Issues Stratified Antibiotic Approach for complicated UTIs
6
Penicillin Allergy Label? Or Antibiotic Overuse?
Conference Coverage
ESC Cardio-Oncology 2025
June 20, 2025
Gut Bacteria Predict Chemotherapy-Related Heart Damage
Clinical Guidelines
View More
August 07, 2025
Metagenomics Reshapes Intensive Care Units
Commentary & Perspectives
View More
August 14, 2025
Who Benefits From Vaccine Misinformation?
FDA & Government News
View More

August 11, 2025
FDA Grants Priority Review to Gepotidacin for Gonorrhea
August 11, 2025